Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 3 selected

Type

Guidance programme 5 selected

Guidance programme

Showing 1 to 10 of 1154

TitleReference numberPublishedLast updated
Tebentafusp for treating advanced uveal melanomaTA1027
Tirzepatide for managing overweight and obesityTA1026
Ublituximab for treating relapsing multiple sclerosisTA1025
Elranatamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsTA1023
Toripalimab with chemotherapy for untreated advanced oesophageal squamous cell cancer (terminated appraisal)TA1024
Crizotinib for treating ROS1-positive advanced non-small-cell lung cancerTA1021
Bevacizumab gamma for treating wet age-related macular degenerationTA1022
Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)NG245
Eplontersen for treating hereditary transthyretin-related amyloidosisTA1020
Asthma pathway (BTS, NICE, SIGN)NG244

Results per page

  1. 10
  2. 25
  3. 50
  4. All